机器人辅助根治性膀胱切除术后印第安纳储尿囊可控性皮肤尿流改道:16年经验
该研究基于2004至2020年前瞻性维护的膀胱癌数据库,纳入97例T1-T4、N0-N1、M0期接受机器人辅助根治性膀胱切除联合印第安纳储尿囊可控性皮肤尿流改道的患者,中位随访93个月,报告30天和90天总体并发症率分别为73.2%和76.5%,主要并发症率分别为17.5%和22.7%,尿控率99.0%,中位总生存108个月。
要点
- 97例患者中91.8%为≤T2期,29.9%接受新辅助化疗,中位随访93个月。
- 30天和90天总体并发症率分别为73.2%和76.5%,主要并发症率分别为17.5%和22.7%。
- 尿控率99.0%,中位总生存108个月,再入院率21.4%。
核心结论
- 印第安纳储尿囊可控性皮肤尿流改道提供优异的功能结局,与其他尿流改道类型相比并发症率可接受。
- 印第安纳储尿囊可控性皮肤尿流改道是可靠的修复选择,借助分步视频参考,作者希望将其提供给更多患者。
研究设计与样本
- 经机构审查委员会批准后,查询前瞻性维护的膀胱癌数据库,纳入2004至2020年在一家三级转诊中心接受根治性膀胱切除联合可控性皮肤尿流改道的T1-T4、N0-N1、M0期膀胱癌患者。
- 共纳入97例患者,中位随访93个月。
主要发现
- 91.8%的患者为≤T2期疾病,29.9%接受新辅助化疗。
- 中位手术时长8.0小时,中位住院时长8.3天,尿控率99.0%。
- 30天和90天总体并发症率分别为73.2%和76.5%,主要并发症(Clavien III-V级)率分别为17.5%和22.7%。
- 最常见的主要并发症为腹腔感染和输尿管结肠狭窄。
- 再入院率为21.4%,中位总生存期为108个月。
临床怎么用
- 作者认为,印第安纳储尿囊可控性皮肤尿流改道是可靠的修复选择,并提供分步视频作为参考,希望将其提供给更多患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Population-based practice patterns in the United States reveal continent diversions are only performed in 8%-10.4% of patients.1-4 Ideally, for patients undergoing radical cystectomy the choice of urinary diversion should be influenced by clinical factors and patient preference, with discussions surrounding quality of life. Unfortunately, receipt of continent diversion has been shown to be influenced by a plethora of other factors such as surgeon preference/training, geography, socioeconomic status, gender, and hospital volume.1-3 Thus, by providing detailed instruction and long-term follow-up, we hope to mitigate some of these disparities by changing the perceptions regarding feasibility and complications of continent diversions. OBJECTIVE: To provide step-by-step instruction and to report long-term clinical outcomes in bladder cancer patients receiving an Indiana pouch continent cutaneous urinary diversion (CCUD) after robot-assisted radical cystectomy. DESIGN, SETTING, AND PARTICIPANTS: After Institutional Review Board approval, a prospectively maintained bladder cancer database was queried for patients with T1-T4, N0-N1, M0 bladder cancer undergoing radical cystectomy with CCUD at a tertiary referral center from 2004 to 2020. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Complications at 30- and 90-day were recorded according to the Clavien-Dindo classification. Continence rates were recorded by chart review. RESULTS AND LIMITATIONS: A total of 97 patients were included with a median follow-up of 93months. Clinically, 91.8% had ≤T2 disease and 29.9% received neoadjuvant chemotherapy. The median length of surgery was 8.0 hours, length of hospital stay was 8.3days, and urinary continence rate was 99.0%. The overall complication rate was 73.2% and 76.5% at 30- and 90-day, respectively. The major complication rate (Clavien III-V) was 17.5% at 30-day and 22.7% at 90-day. The most common major complications were abdominal infection and uretero-colonic stricture. The readmission rate was 21.4% and median overall survival was 108months. CONCLUSION: CCUD provides exceptional functional outcomes with acceptable complication rates compared to other diversion types. CCUD is a reliable reconstructive option and with this step-by-step video as a reference, we hope it will be offered to more patients.
引用
- Kim AH, Ruel NH, Yamzon J, et al. Indiana Pouch Continent Cutaneous Urinary Diversion After Robotic-assisted Radical Cystectomy: A 16-Year Experience. Urology. 2023. PMID: 37951362. doi:10.1016/j.urology.2023.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。